Chemical and structural biology of nucleic acids and protein-nucleic acid complexes for novel drug discovery

Science China Chemistry

Volumn 54, Issue 1, 2011, Pages 3-23

  Gan, Jianhua ^a   Sheng, Jia ^a   Huang, Zhen ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

Author keywords

antibiotics; DNA and RNA; DNA duplex and junction; G quadruplex; inhibitors; nucleic acid targets; protein nucleic acid complexes; ribosome; riboswitch; ribozyme; structure based drug design; therapeutic agents; topoisomerase

Indexed keywords

DNA DUPLEX AND JUNCTION; G-QUADRUPLEXES; INHIBITORS; PROTEIN-NUCLEIC ACID COMPLEXES; RIBOSOME; RIBOSWITCHES; RIBOZYMES; STRUCTURE-BASED DRUG DESIGN; THERAPEUTIC AGENTS; TOPOISOMERASES;

ANTIBIOTICS; BIOMOLECULES; COMPLEXATION; DESIGN; DNA; NUCLEIC ACIDS; PROTEINS; RNA;

DRUG INTERACTIONS;

EID: 79251542076     PISSN: 16747291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11426-010-4174-x     Document Type: Conference Paper

References (181)

1. T.L. Blundell 1996 Structure-based drug design Nature 384 23 26 1:CAS:528:DyaK28Xmsl2rsrk%3D
2. A.K. Ghosh P.R. Sridhar S. Leshchenko A.K. Hussain J. Li A.Y. Kovalevsky D.E. Walters J.E. Wedekind V. Grum-Tokars D. Das Y. Koh K. Maeda H. Gatanaga I.T. Weber H. Mitsuya 2006 Structure-based design of novel HIV-1 protease inhibitors to combat drug resistance J Med Chem 49 17 5252 5261 1:CAS:528:DC%2BD28Xns1Wqu7Y%3D
3. R. Dahm 2008 Discovering DNA: Friedrich Miescher and the early years of nucleic acid research Human Gen 122 6 565 581 1:CAS:528:DC%2BD1cXhvFKgsg%3D%3D
4. G.I. Evan D.T. Littlewood 1993 The role of c-myc in cell growth Curr Opin Genet Dev 3 44 49 1:CAS:528:DyaK3sXitV2kt7o%3D
5. C.J. David M. Chen M. Assanah P. Canoll J.L. Manley 2010 HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer Nature 463 364 368 1:CAS:528:DC%2BD1MXhsFGjsLfO
6. 3• regulatory region Nature 462 803 807 1:CAS:528: DC%2BD1MXhsFersrnF
7. S.H. Orkin C. Porcher Y. Fujiwara J. Visvader L.C. Wang 1999 Intersections between blood cell development and leukemia genes Cancer Res 59 7 1784 1787
8. M.B. Small N. Hay M. Schwab J.M. Bishop 1987 Neoplastic transformation by the human gene N-myc Mol Cell Biol 7 5 1638 1645 1:CAS:528:DyaL2sXksFKksLk%3D
9. J.E. Prescott R.C. Osthus L.A. Lee B.C. Lewis H. Shim J.F. Barrett Q. Guo A.L. Hawkins C.A. Griffin C.V. Dang 2001 A Novel c-Myc-responsive gene, jpo1, participates in neoplastic transformation J Biol Chem 276 48276 48284 1:CAS:528:DC%2BD38XltVGi
10. T. Katan 1982 Resistance to 3,5-dichlorophenyl-N-cyclic imide ('dicarboximide') fungicides in the grey mould pathogen Botrytis cinerea on protected crops. Plant Path 31 2 133 141 1:CAS:528:DyaL38XlvFCnt7s%3D
11. E.J. Threlfall L.R. Ward J.A. Frost J.A. Willshaw 2000 The emergence and spread of antibiotic resistance in food-borne bacteria Int J Food Microbiol 62 1-2 1 5 1:CAS:528:DC%2BD3cXotlClu7s%3D
12. A.J. George 1990 Antimicrobial-resitant pathogens in the Ann Rev Med 199647 169 179
13. M. Morris P.J. Eifel J. Lu P.W. Grigsby C. Levenback R.E. Stevens M. Rotman D.M. Gershenson D.G. Mutch 1999 Pelvic radiation with concurrent chemotherapy with pelvic and para-aortic radiation for high-risk cervical cancer N Engl J Med 340 1137 1143 1:STN:280:DyaK1M3gtVOntg%3D%3D
14. P.G. Rose B.N. Bundy E.B. Watkins J.T. Thigpen G. Deppe M.A. Maiman D.L. Clarke-Pearson S. Insalaco 1999 Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 1144 1153 1:CAS:528:DyaK1MXislKgtLs%3D
15. H.M. Keys B.N. Bundy F.B. Stehman L.I. Muder-spach W.E. Chafe C.L. Suggs J.L. Walker D. Gersell 1999 Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N Engl J Med 340 1154 1161 1:CAS:528:DyaK1MXislKgtLg%3D
16. K. Wang J.F. Lu R.C. Li 1996 The events that occur when cisplatin encounters cells Coord Chem Rev 151 53 88 1:CAS:528:DyaK28XjsVOntbo%3D
17. S.J. Lippard 1982 New chemistry of an old molecule: cis-[Pt(NH3)2Cl2] Science 218 1075 1082 1:CAS:528:DyaL3sXislWmsQ%3D%3D
18. P.M. Takahara A.C. Rosenzweig C.A. Frederick S.J. Lippard 1995 Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin Nature 377 649 652 1:CAS:528:DyaK2MXovVGmt7w%3D
19. J. Zlatanova J. Yaneva S.H. Leuba 1998 Proteins that specifically recognize cisplatin-damaged DNA: A clue to anticancer activity of cisplatin FASEB J 12 791 799 1:CAS:528:DyaK1cXktlCku70%3D
20. U.M. Ohndorf M.A. Rould Q. He C.O. Pabo S.J. Lippard 1999 Molecular basis for recognition of cisplatin-modified DNA by high-mobility group proteins Nature 399 708 712 1:CAS:528:DyaK1MXkt1Sms74%3D
21. N. Farrell L.R. Kelland J.D. Roberts M. Van Beusichem 1992 Activation of the trans geometry in platinum antitumor complexes: A survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action Cancer Res 52 5065 5072 1:CAS:528:DyaK3sXhsFynsw%3D%3D
22. N. Farrell 1996 Current status of structure-activity relationships of platinum anticancer drugs: Activation of the trans-geometry Met Ions Biol Sys 32 603 639 1:CAS:528:DyaK28XivFWnsro%3D
23. M. Coluccia A. Nassi F. Loseto A. Boccarelli M.A. Mariggio D. Giordano F.P. Intini P. Caputo G. Natile 1993 A trans-platinum complex showing higher antitumor activity than the cis-congeners J Med Chem 36 510 512 1:CAS:528:DyaK3sXitVClu7w%3D
24. Y. Najajreh E. Khazanov S. Jawbry Y. Ardeli-Tzaraf J.M. Perez J. Kasparkova V. Brabec Y. Barenholz D. Gibson 2006 Cationic nonsymmetric transplatinum complexes with piperidinopiperidine ligands. Preparation, characterization, in vitro cytotoxicity, in vivo toxicity, and anticancer efficacy studies J Med Chem 49 4665 4673 1:CAS:528:DC%2BD28XmsVKnt7g%3D
25. A.D. Richards A. Rodgers 2007 Synthetic metallomolecules as agents for the control of DNA structure Chem Soc Rev 36 471 483 1:CAS:528: DC%2BD2sXitFWjtLg%3D
26. C.A. Frederick L.D. Williams G. Ughetto G.A. van der Marel J.H. van Boom A. Rich A.H. Wang 1990 Structural comparison of anticancer drug-DNA complexes: Adriamycin and daunomycin Biochemistry 29 2538 2549 1:CAS:528:DyaK3cXhtFWls7c%3D
27. K. Shi B. Pan M. Sundaralingam 2003 Structure of a B-form DNA/RNA chimera (dC)(rG)d(ATGG) complexed with daunomycin at 1.5A resolution Acta Crystalloghr, Sect D 59 1377 1383
28. A.H. Wang Y.G. Gao Y.C. Liaw Y.K. Li 1991 Formaldehyde cross-links daunorubicin and DNA efficiently: HPLC and X-ray diffraction studies Biochemistry 30 3812 3815 1:CAS:528:DyaK3MXhslOqu7s%3D
29. J.A. Cuesta-Seijo G.M. Sheldrick 2005 Structures of complexes between echinomycin and duplex DNA Acta Crystallogr, Sect D 61 442 448
30. Q. Gao L.D. Williams M. Egli D. Rabinovich S.L. Chen G.J. Quigley A. Rich 1991 Drug-induced DNA repair: X-ray structures of a DNA-ditercalinium complex Proc Natl Acad Sci USA 88 2422 2426 1:CAS:528:DyaK3MXhvF2hsb4%3D
31. Q. Gao L.D. Williams M. Egli D. Rabinovic S.L. Chen G.L. Quigley A. Rich R.M. Wartell J.E. Larson R.E. Wells 1974 Netropsin: A specific probe for AT regions of duplex deoxyribonucleic acid J Biol Chem 249 6719 6731
32. C. Zimmer 1975 Effects of the antibiotics netropsin and distamycin A on the structure and function of nucleic acids Mol Biol 15 285 318 1:CAS:528:DyaE2MXkvFWntL0%3D
33. M.L. Kopka C. Yoon D. Goodsell P. Pjura R.E. Dickerson 1985 The molecular origin of DNA-drug specificity in netropsin and distamycin Proc Natl Acad Sci USA 82 5 1376 1380 1:CAS:528:DyaL2MXhslyksbc%3D
34. P.G. Schultz P.B. Dervan 1984 Distamycin and penta-N-methylpyrroleca -rboxamide binding sites on native DNA. A comparison of methidiumpropyl-EDTA- Fe(II) footprinting and DNA affinity cleaving J Biomol Struct Dyn 1 5 1133 1147 1:CAS:528:DyaL2cXitVGit7g%3D
35. C.M. Nunn E. Garman S. Neidle 1997 Crystal structure of the DNA decamer d(CGCAATTGCG) complexed with the minor groove binding drug netropsin Biochemistry 36 16 4792 4799 1:CAS:528:DyaK2sXit1Krtr8%3D
36. X. Chen S.N. Mitra S.T. Rao K. Sekar M. Sundaralingam 1998 A novel end-to-end binding of two netropsins to the DNA decamers d(CCCCCIIIII)2, d(CCCBr5CCIIIII)2 and d(CBr5CCCCIIIII)2 Nucleic Acids Res 26 23 5464 5471 1:CAS:528:DyaK1MXis1Kmsw%3D%3D
37. P.E. Pjura K. Grzeskowiak R.E. Dickerson 1987 Binding of Hoechst 33258 to the minor groove groove of B-DNA J Mol Biol 197 257 271 1:CAS:528:DyaL1cXivVGr
38. M.L. Kopka C. Yoon D. Goodsell P. Pjura R.E. Dickerson 1985 Binding of an antitumor drug to DNA, Netropsin and C-G-C-G-A-A-T-T-BrC-G-C-G J Mol Biol 183 553 563 1:CAS:528:DyaL2MXks1Cms74%3D
39. S.N. Mitra M.C. Wahl M. Sundaralingam 1999 Structure of the side-by-side binding of distamycin tod(GTATATAC)2 Acta Crystallogr, Sect D 55 602 609 1:STN:280:DyaK1M7ptV2gsA%3D%3D
40. D.M. Chenoweth P.B. Dervan 2009 Allosterin modulation of DNA by small molecules Proc Natl Acad Sci USA 106 13175 13179 1:CAS:528:DC%2BD1MXhtVOisbfL
41. K.D. Goodwin E.C. Long M.M. Georgiadis 2005 A host-guest approach for determining drug-DNA interactions: An example using netropsin Nucleic Acids Res 33 13 4106 4116 1:CAS:528:DC%2BD2MXpslOntr0%3D
42. N.G. Nickols C.S. Jacobs M.E. Farkas P.B. Dervan 2007 Improved nuclear localization of DNA-binding polyamides Nucleic Acids Res 35 363 370 1:CAS:528:DC%2BD2sXhtlOlsr0%3D
43. N.G. Nickols P.B. Dervan 2007 Suppression of androgen receptormediated gene expression by a sequence-specific DNA-binding polyamide Proc Natl Acad Sci USA 104 10418 10423 1:CAS:528:DC%2BD2sXnt1Kktr4%3D
44. C.S. Jacobs P.B. Dervan 2009 Modifications at the C-terminus to improve pyrrole-imidazole polyamide activity in cell culture J Med Chem 52 23 7380 7388 1:CAS:528:DC%2BD1MXotVGksr0%3D
45. T. Le Doan L. Perrouault D. Praseuth N. Habhoub J.L. Decout N.T. Thuong 1987 Sequence-specific recognition, photocrosslinking and cleavage of the DNA double helix by an oligo-[alpha]-thymidylate covalently linked to an azidoproflavine derivative Nucleic Acids Res 15 7749 7760
46. H.E. Moser P.B. Dervan 1987 Sequence-specific cleavage of double helical DNA by triple helix formation Science 238 645 650 1:CAS:528:DyaL1cXltVKitA%3D%3D
47. V.A. Malkov V.N. Soyfer M.D. Frank-Kamenetskii 1992 Effect of intermolecular triplex formation on the yield of cyclobutane photodimers in DNA Nucleic Acids Res 20 18 488948 95
48. S.M. Mirkin M.D. Frank-Kamenetskii 1994 H-DNA and related structures Annu Rev Biophys Biomol Struct 23 541 576 1:CAS:528:DyaK2MXitVaruw%3D%3D
49. T.L. Davis A.B. Firulli A.J. Kinniburgh 1989 Ribonucleoprotein and protein factors bind to an H-DNA-forming cmyc DNA element: Possible regulators of the c-myc gene Proc Natl Acad Sci USA 86 9682 9686 1:CAS:528: DyaK3cXhtlemsro%3D
50. R. Zain J.S. Sun 2003 Do natural DNA triple-helical structures occur and function in vivo? Cell Mol Life Sci 60 862 870 1:CAS:528:DC%2BD3sXlt1ait7c%3D
51. P.E. Nielsen M. Egholm R.H. Berg O. Buchardt 1991 Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide Science 254 1497 1500 1:CAS:528:DyaK38XhsVKgsr4%3D
52. V. Menchise G. De Simone T. Tedeschi R. Corradini S. Sforza R. Marchelli D. Capasso M. Saviano C. Pedone 2003 Insights into peptide nucleic acid (PNA) structural features: the crystal structure of D-lysine-based chiral PNA-DNA duplex Proc Natl Acad Sci USA 100 12021 12026 1:CAS:528:DC%2BD3sXotlGltb8%3D
53. M. Egholm O. Buchardt L. Christensen C. Behrens S.M. Freier D.A. Driver R.H. Berg S.K. Kim B. Norden P.E. Nielsen 1993 PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogenbonding rules Nature 365 566 568 1:CAS:528:DyaK2cXntFOksQ%3D%3D
54. L. Betts J.A. Josey J.M. Veal S.R. Jordan 1995 A nucleic acid triplex formed by a nucleic acid-DNA complex Science 270 1838 1841 1:CAS:528: DyaK2MXhtVSiurbJ
55. U. Koppelhus S.K. Awasthi V. Zachar H.U. Holst P. Ebbesen P.E. Nielsen 2002 Cell-dependent differential cellular uptake of PNA, peptides, and PNApeptide conjugates Antisense Nucl Acid Drug Develop 12 51 63 1:CAS:528:DC%2BD38Xks12htb4%3D
56. P. Zhou M.M. Wang L. Du G.W. Fisher A. Waggoner D.H. Ly 2003 Novel binding and efficient cellular uptake of guanidine-based peptide nucleic acids (GPNA) J Am Chem Soc 125 6878 6879 1:CAS:528:DC%2BD3sXjsl2hs7c%3D
57. Dragulescu-Andrasi A, Zhou P, He GF, Ly DH. Cell-permeable GPNA with appropriate backbone stereochemistry and spacing binds sequencespecifically to RNA. Chem Comm, 2005, 244-246
58. + human hematopoietic progenitors. Mol Ther, 2010, doi:10.1038/mt.2010 doi:10.1038/mt.2010
59. R.R. Sinden V.N. Potaman E.A. Oussatcheva C.E. Pearson Y.L. Lyubchenko L.S. Shlyakhtenko 2002 Triplet repeat DNA structures and human genetic disease: Dynamic mutations from dynamic DNA J Biosci 27 1 53 65 1:CAS:528: DC%2BD38Xjt1Ciurc%3D
60. C.E. Pearson R.R. Sinden 1996 Alternative structures in duplex DNA formed within the trinucleotide repeats of the myotonic dystrophy and fragile X loci Biochemistry 35 5041 5053 1:CAS:528:DyaK28XhvVCls7c%3D
61. A. Oleksy A.G. Blanco R. Boer I. Usón J. Aymamí A. Rodger M.J. Hannon M. Coll 2006 Molecular recognition of a three-way DNA junction by a metallosupramolecular helicate Angew Chem Int Ed Engl 13 1227 1231
62. L. Cerasino M.J. Hannon E. Sletten 2007 DNA three-way junction with a dinuclear iron(II) supramolecular helicate at the center: A NMR structural study Inorg Chem 46 16 6245 6251
63. M. Ortiz-Lombardía A. González R. Eritja J. Aymamí F. Azorín M. Coll 1999 Crystal structure of a DNA Holliday junction Nat Struct Biol 6 10 913 917
64. H.E. Bryant N. Schultz H.D. Thomas K.M. Parker D. Flower E. Lopez S. Kyle M. Meuth N.J. Curtin T. Helleday 2005 Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase Nature 434 913 917 1:CAS:528:DC%2BD2MXjtFOmsrY%3D
65. H. Farmer N. McCabe C.J. Lord A.N. Tutt D.A. Johnson T.B. Richardson M. Santarosa K.J. Dillon I. Hickson C. Knights N.M. Martin S.P. Jackson G.C. Smith A. Ashworth 2005 Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy Nature 434 917 921 1:CAS:528:DC%2BD2MXjtFOmsrc%3D
66. A.L. Brogden N.H. Hopcroft M. Searcey C.J. Cardin 2007 Ligand bridging of the DNA Holliday junction: molecular recognition of a stacked-X four-way junction by a small molecule Angew Chem Int Ed Engl 46 21 3850 3854 1:CAS:528:DC%2BD2sXmtFOnsr4%3D
67. Simonsson T, G-quadruplex DNA structures-variations on a theme. Biol Chem, 2001, 621-628
68. C. Schaffitzel I. Berger J. Postberg J. Hanes H.J. Lipps A. Pluckthun 2001 In vitro generated antibodies specific for telomeric guanine-quadruplex DNA react with Stylonychia lemnae macronuclei Proc Natl Acad Sci USA 98 8572 8577 1:CAS:528:DC%2BD3MXls1Witr4%3D
69. G.N. Parkinson M.P.H. Lee S. Neidle 2002 Crystal structure of parallel quadruplexes from human telomeric DNA Nature 417 876 880 1:CAS:528: DC%2BD38Xks1Wlsr8%3D
70. S.M. Haider G.N. Parkinson S. Neidle 2002 Crystal structure of the potassiumform of an Oxytricha nova G-quadruplex J Mol Biol 320 189 200 1:CAS:528:DC%2BD38XkslansLg%3D
71. M.L. Gill S.A. Strobel J.P. Loria 2006 Crystallization and characterization of the thallium form of the Oxytricha nova G-quadruplex Nucleic Acids Res 34 4506 4514 1:CAS:528:DC%2BD28XhtVygu7nK
72. P. Hazel G.N. Parkinson S. Neidle 2006 Topology variation and loop structural homology in crystal and simulated structures of a bimolecular DNA quadruplex J Am Chem Soc 128 5480 5487 1:CAS:528:DC%2BD28XjtVygtb0%3D
73. J. Deng Y. Xiong M. Sundaralingam 2001 X-ray analysis of an RNA tetraplex (UGGGGU)(4) with divalent Sr(2p) ions at subatomic resolution Proc Natl Acad Sci USA 98 13665 13670 1:CAS:528:DC%2BD3MXovVynsb0%3D
74. B. Pan K. Shi M. Sundaralingam 2006 Crystal structure of an RNA quadruplex containing inosine tetrad: Implications for the roles of NH2 group in purine tetrads J Mol Biol 363 451 459 1:CAS:528:DC%2BD28XhtVajsLjJ
75. K. Phillips Z. Dauter A.I. Murchie D.M. Lilley B. Luisi 1997 The crystal structure of a parallel-stranded guanine tetraplex at 0.95 A resolution J Mol Biol 273 171 182 1:CAS:528:DyaK2sXmvFymtLs%3D
76. S.M. Haider G.N. Parkinson S. Neidle 2003 Structure of a G-quadruplexligand complex J Mol Biol 326 117 125 1:CAS:528: DC%2BD3sXlt12huw%3D%3D
77. G.R. Clark P.D. Pytel C.J. Squire S. Neidle 2003 Structure of the first parallel DNA quadruplex complex J Am Chem Soc 125 4066 4067 1:CAS:528: DC%2BD3sXitVOls7w%3D
78. G.N. Parkinson R. Ghosh S. Neidle 2007 Structural basis for binding of porphyrin to human telomeres Biochemistry 46 2390 2397 1:CAS:528: DC%2BD2sXht1Kisbc%3D
79. A.K. Todd M. Johnston S. Neidle 2005 Highly prevalent putative quadruplex sequence motifs in human DNA Nucleic Acids Res 33 2901 2907 1:CAS:528:DC%2BD2MXkvVSgsrw%3D
80. J.L. Huppert S. Balasubramanian 2005 Prevalence of quadruplexes in the human genome Nucleic Acids Res 33 2908 2916 1:CAS:528:DC%2BD2MXkvVSgsL0%3D
81. A. Siddiqui-Jain C.L. Grand D.J. Bearss L.H. Hurley 2002 Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription Proc Natl Acad Sci USA 99 11593 11598 1:CAS:528:DC%2BD38XntFWqsL4%3D
82. M. Mandal R.R. Breaker 2004 Gene regulation by riboswitches Nat Rev Mol Cell Biol 5 451 463 1:CAS:528:DC%2BD2cXksVarsLc%3D
83. B.J. Tucker R.R. Breaker 2005 Riboswitches as versatile gene control elements Curr Opin Struct Biol 15 342 348 1:CAS:528:DC%2BD2MXlt1SrsLc%3D
84. W.C. Winkler R.R. Breaker 2005 Regulation of bacterial gene expression by riboswitches Annu Rev Microbiol 59 487 517 1:CAS:528:DC%2BD2MXht1ShsL7P
85. M. Mandal M. Lee J.E. Barrick Z. Weinberg G.M. Emilsson W.L. Ruzzo R.R. Breaker 2004 A glycine-dependent riboswitch that uses cooperative binding to control gene expression Science 306 275 279 1:CAS:528:DC%2BD2cXotFWns7c%3D
86. N. Sudarsan J.K. Wickiser S. Nakamura M.S. Ebert R.R. Breaker 2003 An mRNA structure in bacteria that controls gene expression by binding lysine Genes Dev 17 2688 2697 1:CAS:528:DC%2BD3sXovVahtL8%3D
87. J.M. Lee S.H. Zhang S. Saha S.S. Anna C. Jiang J. Perkins 2001 RNA expression analysis using an antisense Bacillus subtilis genome array J Bacteriol 183 7371 7380 1:CAS:528:DC%2BD3MXovVShu70%3D
88. J. Lim W.C. Winkler S. Nakamura V. Scott R.R. Breaker 2006 Molecular-recognition characteristics of SAM-binding riboswitches Angew Chem Int Ed Engl 45 964 968 1:CAS:528:DC%2BD28XhsFKmsbg%3D
89. W.C. Winkler S. Cohen-Chalamish R.R. Breaker 2002 An mRNA structure that controls gene expression by binding FMN Proc Nat Acad Sci USA 99 15908 15913 1:CAS:528:DC%2BD38Xps1egurw%3D
90. J.K. Wickiser W.C. Winkler R.R. Breaker D.M. Crothers 2005 The speed of RNA transcription and metabolite binding kinetics operate an FMN riboswitch Mol Cell 18 49 60 1:CAS:528:DC%2BD2MXjt1Oit7s%3D
91. A. Nahvi J.E. Barrick R.R. Breaker 2004 Coenzyme B12 riboswitches are widespread genetic control elements in prokaryotes Nucleic Acids Res 32 143 150 1:CAS:528:DC%2BD2cXhtlKgtb4%3D
92. W. Winkler A. Nahvi R.R. Breaker 2002 Thiamine derivatives bind messenger RNAs directly to regulate bacterial gene expression Nature 419 952 956 1:CAS:528:DC%2BD38Xot1Kluro%3D
93. D.A. Rodionov A.G. Vitreschak A.A. Mironov M.S. Gelfand 2002 Comparative genomics of thiamin biosynthesis in procaryotes. New genes and regulatory mechanisms J Biol Chem 277 48949 48959 1:CAS:528:DC%2BD38Xptlentbk%3D
94. N. Kulshina N.J. Baird A.R. Ferré-D'Amare 2009 Recognition of the bacterial second messenger cyclic diguanylate by its cognateriboswitch Nat Struct Mol Biol 16 1212 1217 1:CAS:528:DC%2BD1MXhtlOrurrE
95. A. Serganov L.L. Huang D.J. Patel 2009 Conzyme recognition and gene regulation by a flavinmononucleotide riboswitch Nature 458 233 237 1:CAS:528:DC%2BD1MXht1ehtrY%3D
96. A.D. Garst A. Heroux R.P. Rambo R.T. Batey 2008 Crystal structure of the lysine riboswitch regulatory mRNA element J Biol Chem 283 22347 22351 1:CAS:528:DC%2BD1cXpsVKmsro%3D
97. D.J. Klein T.E. Edwars A.R. Ferré-D'Amare 2009 Cocrystal structure of a class I preQ1 riboswitch reveals apseudoknot recognizing an essential hypermodifiednucleobase Nat Struct Mol Biol 16 343 1:CAS:528: DC%2BD1MXitFKks7o%3D
98. W.J. Robbins 1941 The pyridine analog of thiamine and the growth of fungi Proc Natl Acad Sci USA 27 419 422 1:CAS:528:DyaH3MXltFOktg%3D%3D
99. D.W. Woolley A.G.C. White 1943 Selective reversible inhibition of microbial growth with pyrithiamine J Exp Med 78 489 497 1:CAS:528:DyaH2cXjslal
100. Shiota T, Folk JE, Tietze F. Inhibition of lysine utilization in bacteria by S-(betaaminoethyl) cysteine and its reversal by lysine peptides. Arch Biochem Biophys, 1958, 77; 372-377
101. T. McCord J. Ravel C. Skinner W. Shive 1957 dl-4-Oxalysine, an inhibitory analog of lysine J Am Chem Soc 79 5693 5696 1:CAS:528:DyaG1cXivFKqtQ%3D%3D
102. K. Matsui H.C. Wang T. Hirota H. Matsukawa S. Kasai 1982 Riboflavin production by roseoflavin-resistant strains of some bacteria Agric Biol Chem 46 2003 2008 1:CAS:528:DyaL38XlsVWnsro%3D
103. V.M. Berezovskii A.I. Stepanov N.A. Polyakova L.S. Tulchinskaya A.Y. Kukanova 1977 Studies of a group of allo- and isoallxazine XLVI. Synthesis and biological specificity of amino analogs. Bioorg Khim 3 521 524 1:CAS:528:DyaE2sXltVamtbs%3D
104. F. Michel K. Umesono H. Ozeki 1989 Comparative and functional anatomy of group II catalytic introns a review Gene 82 5 30 1:CAS:528:DyaL1MXmtV2kurs%3D
105. T.R. Cech 1990 Self-splicing of group I introns Annu Rev Biochem 59 543 568 1:CAS:528:DyaK3cXltFSjsbY%3D
106. F. Eckstein B. Bramlage 1999 The hammerhead ribozyme Biopolymers 52 147 154 1:CAS:528:DC%2BD3MXpvFymtQ%3D%3D
107. D. Ruffner S. Dahm O. Uhlenbeck 1989 Studies on the hammerhead RNA self-cleaving domain Gene 82 1 31 41 1:CAS:528:DyaL1MXmtFSju74%3D
108. V.N. Lazarev M.M. Shmarov A.N. Zakhartchouk G.K. Yurov O.U. Misurina T.A. Akopian N.F. Grinenko N.G. Grodnitskaya N.V. Kaverin B.S. Naroditsky 1999 Inhibition of influenza A virus reproduction by a ribozyme targeted against PB1 mRNA Antiviral Res 42 47 57 1:CAS:528:DyaK1MXisV2htLg%3D
109. N. Sakamoto C.H. Wu G.Y. Wu 1996 Intracellular cleavage of hepatitis C virus RNA and inhibition of viral protein translation by hammerhead ribozymes J Clin Invest 98 2720 2728 1:CAS:528:DyaK2sXis1Sk
110. G. Ideo A. Bellobuono 2002 New therapies for the treatment of chronic hepatitis C Curr Pharm Des 8 959 966 1:CAS:528:DC%2BD38XjtlGrs7o%3D
111. Y. Feng Y.Y. Kong Y. Wang G.R. Qi 2001 Intracellular inhibition of the replication of hepatitis B virus by hammerhead ribozymes J Gastroenterol Hepatol 16 1125 1130 1:CAS:528:DC%2BD3MXpt1Sqt7w%3D
112. P. Trang K. Lee A.F. Kiliani J. Kim F. Liu 2001 Effective inhibition of herpes simplex virus 1 gene expression and growth by engineered RNase P ribozyme Nucleic Acids Res 29 5071 5078 1:CAS:528:DC%2BD38XmslahtQ%3D%3D
113. P. Trang M. Lee E. Nepomuceno J. Kim H. Zhu F. Liu 2000 Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli Proc Natl Acad Sci USA 97 5812 5817 1:CAS:528:DC%2BD3cXjvFaktLw%3D
114. O. Yamada M. Yu J.K. Yee G. Kraus D. Looney F. Wong-Staal 1994 Intracellular immunization of human T cells with a hairpin ribozyme against human immunodeficiency virus type 1 Gene Ther 1 34 45
115. J. Bai N. Banda N.S. Lee J. Rossi R. Akkina 2002 RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model Mol Ther 6 770 782 1:CAS:528:DC%2BD38XpslWksbc%3D
116. R. Akkina A. Banerjea J. Bai J. Anderson M.J. Li J. Rossi 2003 siRNAs, ribozymes and RNA decoys in modelling stem cell-based gene therapy for HIV/AIDS Anticancer Res 23 1997 1005 1:CAS:528:DC%2BD3sXmsFyrs7k%3D
117. M. Scherr A.B. Maurer S. Klein A. Ganser J.W. Engels M. Grez 1998 Effective reversal of a transformed phenotype by retrovirusmediated transfer of a ribozyme directed against mutant N-ras Gene Ther 5 1227 1234 1:CAS:528:DyaK1cXmtVOms7Y%3D
118. G. Schwab C. Chavany I. Duroux G. Goubin J. Lebeau C. Helene T. Saisonbehmoaras 1994 Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated H-rasmediated cell proliferation and tumorigenicity in nude mice Proc Natl Acad Sci USA 91 10460 10464 1:CAS:528:DyaK2MXhslelsr0%3D
119. F. Bi D. Fan H. Hui C. Wang X. Zhang 2001 Reversion of the malignant phenotype of gastric cancer cells SGC7901 by c-erbB-2-specific hammerhead ribozyme Cancer Gene Ther 8 835 842 1:CAS:528:DC%2BD3MXovVektb8%3D
120. R. Abounader B. Lal C. Luddy G. Koe B. Davidson E.M. Rosen J. Laterra 2002 In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis FASEB J 16 108 110 1:CAS:528:DC%2BD38XlsF2rsA%3D%3D
121. R. Parthasarathy G.J. Cote R.F. Gagel 1999 Hammerhead ribozymemediated inactivation of mutant RET in medullary thyroid carcinoma Cancer Res 59 3911 3914 1:CAS:528:DyaK1MXlsVOlt7w%3D
122. Deiner TO. Viroids and Viroid Diseases. New York: Wiley, 1979
123. C.C. Sheldon R.H. Symons 1993 Is hammerhead self-cleavage involved in the replication of a virusoid in vivo? Virology 194 2 463 474 1:CAS:528: DyaK3sXks1Okt7Y%3D
124. A.C. Pease D.E. Wemmer 1990 Characterization of the secondary structure and melting of a self-cleaved RNA hammerhead domain by 1H NMR spectroscopy Biochemistry 29 38 9039 9046 1:CAS:528:DyaK3cXlsVOqt7g%3D
125. C. Hernández R. Flores 1992 Plus and minus RNAs of peach latent mosaic viroid self-cleave in vitro via hammerhead structures Proc Natl Acad Sci USA 89 9 3711 3715
126. C. Hernández J.A. Daròs S.F. Elena A. Moya R. Flores 1992 The strands of both polarities of a small circular RNA from carnation self-cleave in vitro through alternative double- and single-hammerhead structures Nucleic Acids Res 20 23 6323 6329
127. T.K. Stage K.J. Hertel O.C. Uhlenbeck 1995 Inhibition of the hammerhead ribozyme by neomycin RNA 1 1 95 101 1:CAS:528:DyaK2MXkvFemurY%3D
128. W. Dürckheimer 1975 Tetracyclines: Chemistry, biochemistry, and structure-activity relations Angew Chem Int Ed Engl 14 11 721 734
129. U. von Ahsen J. Davies R. Schroeder 1991 Antibiotic inhibition of group I ribozyme function Nature 353 368 370
130. U. von Ahsen J. Davies R. Schroeder 1992 Non-competitive inhibition of group I intron RNA self-splicing by aminoglycoside antibiotics J Mol Biol 226 4 935 941
131. P.L. Adams M.R. Stahley A.B. Kosek J. Wang S.A. Strobel 2004 Crystal structure of a self-splicing group I intron with both exons Nature 430 45 50 1:CAS:528:DC%2BD2cXlt1CqtL8%3D
132. J. Karn 1999 Tackling Tat J Mol Biol 293 2 235 254 1:CAS:528: DyaK1MXms12rtb4%3D
133. M.L. Zapp S. Stern M.R. Green 1993 Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production Cell 74 6 969 978 1:CAS:528:DyaK3sXlvFGiurY%3D
134. C. Faber H. Sticht K. Schweimer P. Rosch 2000 Structural rearrangements of HIV-1 Tat-responsive RNAupon binding of neomycin B J Biol Chem 275 20660 20666 1:CAS:528:DC%2BD3cXkvVyhsbk%3D
135. A. Davidson T.C. Leeper Z. Athanassiou K. Patora-Komisarska J. Karn J.A. Robinson G. Varani 2009 Stimultaneous recognition of HIV-1 TAR RNA bulge and loopsequences by cyclic peptide mimics of Tat protein Proc Natl Acad Sci USA 106 11931 11936 1:CAS:528:DC%2BD1MXps1antLc%3D
136. J.M. Ogle A.P. Carter V. Ramakrishnan 2003 Insights into the decoding mechanism from recent ribosome structures Trends Biochem Sci 28 259 266 1:CAS:528:DC%2BD3sXjvFWlt7c%3D
137. T. Auerbach A. Bashan A. Yonath 2004 Ribosomal antibiotics:structural basis for resistance, synergism and selectivity Trends Biotechnol 22 570 576 1:CAS:528:DC%2BD2cXos1yqsbc%3D
138. D.J.C. Knowles N. Foloppe N.B. Matassova A.I.H. Murchie 2002 The bacterial ribosome, a promising focus for structure-based drug design Curr Opin Pharmacol 2 501 506 1:CAS:528:DC%2BD38Xnt1Ckuro%3D
139. Q. Vicens E. Westhof 2003 RNA as a drug target: the case of aminoglycosides ChemBioChem 4 1018 1023 1:CAS:528:DC%2BD3sXotlSrt7k%3D
140. T.M. Schmeing R.M. Voorhees A.C. Kelley Y.G. Gao F.V. Murphy J.R. Weir V. Ramakrishnan 2009 The crystal structure of the ribosome bound to EF-Tu andaminoacyl-tRNA Science 326 688 694 1:CAS:528:DC%2BD1MXhtlagtLrO
141. D. Moazed H.F. Noller 1987 Interaction of antibiotics with functional sites in 16S ribosomal RNA Nature 327 389 394 1:CAS:528:DyaL2sXkvFaisbY%3D
142. P. Purohit S. Stern 1994 Interactions of a small RNA with antibiotics and RNA ligands of the 30S subunit Nature 370 659 662 1:CAS:528: DyaK2MXls1Wrug%3D%3D
143. H. Miyaguchi H. Narita K. Sakamoto S. Yokoyama 1996 An antibiotic-binding motif of an RNA fragment derived from the A-site related region of Escherichia coli 16S RNA Nucleic Acids Res 24 3700 3706 1:CAS:528:DyaK28Xmt1ahu7w%3D
144. M.I. Recht D. Fourmy S.C. Blanchard K.D. Dahlquist J.D. Puglisi 1996 RNA sequence determinants for aminogly-glycosides J Mol Biol 262 421 436 1:CAS:528:DyaK28XmtF2htb8%3D
145. S.C. Blanchard D. Fourmy R.G. Eason J.D. Puglisi 1998 rRNA chemical groups required for aminoglycoside binding Biochemistry 37 7716 7724 1:CAS:528:DyaK1cXis12rtL0%3D
146. Q. Vicens E. Westhof 2003 Crystal structure of geneticin bound to a bacterial 16S ribosomal RNA A site oligonucleotide J Mol Biol 326 1175 1188 1:CAS:528:DC%2BD3sXhtVCitbk%3D
147. R.J. Russell J.B. Murray G. Lentzen J. Haddad S. Mobashery 2003 The complex of a designer antibiotic with a model aminoacyl site of the 30S ribosomal subunit revealed by X-ray crystallography J Am Chem Soc 125 3410 3411 1:CAS:528:DC%2BD3sXhsFWit70%3D
148. B. Francois J. Szychowski S.S. Adhikari K. Pachamuthu E.E. Swayze R.H. Griffey M.T. Migawa E. Westhof S. Hanessian 2004 Anti-bacterial aminoglycosides with a modified mode of binding to the ribosomal-RNA decoding site Angew Chem Int Ed Engl 43 6735 6738 1:CAS:528:DC%2BD2MXoslOj
149. D. Vourloumis G.C. Winters K.B. Simonsen M. Takahashi B.K. Ayida S. Shandrick Q. Zhao Q. Han T. Hermann 2005 Aminoglycoside-hybrid ligands targeting the ribosomal decoding site ChemBioChem 6 58 65 1:CAS:528: DC%2BD2MXnvFKgsA%3D%3D
150. M.V. Rodnina W. Wintermeyer 2003 Peptide bond formation on the ribosome: Structure and mechanism Curr Opin Struct Biol 13 334 340 1:CAS:528: DC%2BD3sXkvVKnsrk%3D
151. M.R. Barbachyn C.W. Ford 2003 Oxazolidinone structure-activity relationships leading to linezolid Angew ChemInt Ed Engl 42 2010 2023 1:CAS:528:DC%2BD3sXkt1Snu7k%3D
152. 1H nuclear magnetic resonance study of oxazolidinone binding to bacterial ribosomes Antimicrob Agents Chemother 46 625 629 1:CAS:528:DC%2BD38XhsVKht7g%3D
153. J.M. Harms H. Bartels F. Schlunzen A. Yonath 2003 Antibiotics acting on the translational machinery J Cell Sci 116 1391 1393 1:CAS:528: DC%2BD3sXjtlyrt7Y%3D
154. J.L. Hansen P.B. Moore T.A. Steitz 2003 Structures of five antibiotics bound at the peptidyl transferase center of the large ribosomal subunit J Mol Biol 330 1061 1075 1:CAS:528:DC%2BD3sXlt1aqu70%3D
155. J.M. Harms F. Schlunzen P. Fucini H. Bartels A.J. Yonath 2004 Alterations at the peptidyl transferase centre of the ribosome induced by the synergistic action of the streptogramins dalfopristin and quinupristin BMC Biol 2 4 4
156. J.L. Hansen J.A. Ippolito N. Ban P. Nissen P.B. Moore T.A. Steitz 2002 The structures of four macrolide antibiotics bound to the large ribosomal subunit Mol Cell 10 117 128 1:CAS:528:DC%2BD38XmtFaktb0%3D
157. F. Schluenzen J.M. Harms F. Franceschi H.A. Hansen H. Bartels R. Zarivach A. Yonath 2003 Structural basis for the antibiotic activity of ketolides and azalides Structure 11 329 338
158. R. Berisio J. Harms F. Schluenzen R. Zarivach H.A. Hansen P. Fucini A. Yonath 2003 Structural insight into the antibiotic action of telithromycin against resistant mutants J Bacteriol 185 4276 4279 1:CAS:528: DC%2BD3sXlsFahtrY%3D
159. R. Berisio F. Schluenzen J. Harms A. Bashan T. Auerbach D. Baram A. Yonath 2003 Structural insight into the role of the ribosomal tunnel in cellular regulation Nat Struct Biol 10 366 370 1:CAS:528:DC%2BD3sXjtFKnsro%3D
160. J.L. Hansen J.A. Ippolito N. Ban P. Nissen P.B. Moore T.A. Steitz 2002 The structures of four macrolide antibiotics bound to the large ribosomal subunitt Mol Cell 10 117 128 1:CAS:528:DC%2BD38XmtFaktb0%3D
161. L.F. Liu 1989 DNA topoisomerase poisons as antitumor drugs Ann Rev Biochem 58 351 375 1:CAS:528:DyaL1MXkslSiu70%3D
162. K.D. Corbett J.M. Berger 2004 Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases Annu Rev Biophys Biomol Struct 33 95 118 1:CAS:528:DC%2BD2cXltlKktr0%3D
163. J.L. Nitiss 2002 DNA topoisomerases in cancer chemotherapy: Using enzymes to generate selective DNA damage Curr Opin Investig Drugs 3 1512 1516 1:CAS:528:DC%2BD3sXhsVGjsbw%3D
164. K. Drlica M. Malik R.J. Kerns X. Zhao 2008 Quinolonemediated bacterial death Antimicrob Agents Chemother 52 385 392 1:CAS:528:DC%2BD1cXhtlSqtLc%3D
165. Forterre P, Gribaldo S, Gadelle D, Serre M C. Origin and evolution of DNA topoisomerases. Biochimie, 2007, 427-446
166. C.R. Lopez S. Yang R.W. Deibler S.A. Ray J.M. Pennington R.J. Digate P.J. Hastings S.M. Rosenberg E.L. Zechiedrich 2005 A role for topoisomerase III in a recombination pathway alternative to RuvABC Mol Microbiol 58 80 101 1:CAS:528:DC%2BD2MXhtFWit73M
167. X. Tabary N. Moreau C. Dureuil F. Le Goffic 1987 Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin, and clorobiocin on Escherichia coli topoisomerase I Antimicrob Agents Chemother 31 1925 1928 1:CAS:528:DyaL1cXntF2nsA%3D%3D
168. B.L. Staker K. Hjerrild M.D. Feese C.A. Behnke A.B. Burgin L. Stewart 2002 The mechanism of topoisomerase I poisoning by a camptothecin analog Proc Natl Acad Sci USA 99 24 15387 15392 1:CAS:528:DC%2BD3sXjvVGh
169. J.E. Chrencik A.B. Burgin Y. Pommier L. Stewart M.R. Redinbo 2003 Structural impact of the leukemia drug 1-β-d-Arabinofuranosyt-osine (Ara-C) on the covalent human topoisomerase I-DNA complex J Biol Chem 278 14 12461 12466 1:CAS:528:DC%2BD3sXisVOntb8%3D
170. A. Bergerat D. Gadelle P. Forterre 1994 Purification of a DNA topoisomerase II from the hyperthermophilic archaeon Sulfolobus sh tures J Biol Chem 269 27663 27669 1:CAS:528:DyaK2cXmsV2itLk%3D
171. A. Bergerat B. De Massy D. Gadelle P.C. Varoutas A. Nicolas P. Forterre 1999 An atypical topoisomerase II from archaea with implications for meiotic recombination Nature 386 414 417
172. Coates WJ. et al. Preparation of piperidinylalkylquinolines as antibacterials. European Patent, 1999, 051413
173. J.J. Wiener L. Gomez H. Venkatesan A. Santillán Jr B.D. Allison K.L. Schwarz S. Shinde L. Tang M.D. Hack B.J. Morrow S.T. Motley R.M. Goldschmidt K.J. Shaw T.K. Jones C.A. Grice 2007 Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrugresistant strains Bioorg Med Chem Lett 7 2718 2722
174. M.T. Black T. Stachyra D. Platel A.M. Girard M. Claudon J.M. Bruneau C. Miossec 2008 Mechanism of action of the antibiotic NXL101, a novel nonfluoroquinolone inhibitor of bacterial type II topoisomerases Antimicrob Agents Chemother 52 3339 3349 1:CAS:528:DC%2BD1cXhtF2gt77L
175. B.D. Bax P.F. Chan D.S. Eggleston A. Fosberry D.R. Gentry F. Gorrec L. Giordano M.M. Hann A. Hennessy M. Hibbs J.Z. Huang E. Jones J. Jones K.K. Brown C.J. Lewis E.W. May M.R. Saunders O. Singh C.E. Spitzfaden C. Shen A. XShillings A.J. Theobald A. Wohlkonig N.D. Pearson M.N. Gwynn 2010 Type IIA topoisomerase inhibition by a new class of antibacterial agents Nature 466 935 939
176. J. Sheng Z. Huang 2010 Selenium derivatization of nucleic acids for X-ray crystal structure and function studies Chem Biodiver 7 753 785 1:CAS:528:DC%2BC3cXltVygtLw%3D
177. J. Sheng J. Salon J.-H. Gan Z. Huang 2010 Synthesis and crystal structure study of 2′-Se-adenosine-derivatized DNA Sci China Chem 53 78 85 1:CAS:528:DC%2BC3cXjslarurc%3D
178. A.E.A. Hassan J. Sheng W. Zhang Z. Huang 2010 High fidelity of base paring by 2-selenothymidine in DNA J Am Chem Soc 132 2120 2121 1:CAS:528:DC%2BC3cXht1Sgtrs%3D
179. J. Salon J. Jiang J. Sheng O.O. Gerlits Z. Huang 2008 Derivatization of DNAs with selenium at 6-position of guanine for function and crystal structure studies Nucleic Acids Res 36 7009 7018 1:CAS:528:DC%2BD1cXhsV2rsrnK
180. J. Caton-Williams Z. Huang 2008 Synthesis and DNA polymerase incorporation of colored 4-selenothymidine triphosphate with a single atom substitution Angew Chem Int Ed Engl 47 1723 1725 1:CAS:528:DC%2BD1cXis1yjsr4%3D
181. J. Salon J. Sheng J.-H. Gan Z. Huang 2010 Synthesis and crystal structure of 2′-Se-modified guanosine containing DNA J Org Chem 75 637 641 1:CAS:528:DC%2BC3cXhtFKmug%3D%3D